NewEdge Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Buy |
8,577
+5,205
| +154% | +$253K | ﹤0.01% | 1806 |
|
|
2025
Q1 | $115K | Sell |
3,372
-4,048
| -55% | -$138K | ﹤0.01% | 2254 |
|
|
2024
Q4 | $292K | Buy |
7,420
+1,622
| +28% | +$63.8K | ﹤0.01% | 1897 |
|
|
2024
Q3 | $272K | Sell |
5,798
-3,725
| -39% | -$175K | ﹤0.01% | 1864 |
|
|
2024
Q2 | $514K | Buy |
9,523
+441
| +5% | +$23.8K | ﹤0.01% | 1409 |
|
|
2024
Q1 | $619K | Buy |
9,082
+7,110
| +361% | +$485K | 0.01% | 1221 |
|
|
2023
Q4 | $123K | Buy |
1,972
+663
| +51% | +$41.5K | ﹤0.01% | 1876 |
|
|
2023
Q3 | $59.4K | Sell |
1,309
-30
| -2% | -$1.36K | ﹤0.01% | 2039 |
|
|
2023
Q2 | $75.2K | Sell |
1,339
-694
| -34% | -$39K | ﹤0.01% | 1949 |
|
|
2023
Q1 | $92K | Sell |
2,033
-10,697
| -84% | -$484K | ﹤0.01% | 1773 |
|
|
2022
Q4 | $405K | Sell |
12,730
-2,410
| -16% | -$76.6K | 0.01% | 873 |
|
|
2022
Q3 | $989K | Buy |
+15,140
| New | +$989K | 0.02% | 648 |
|